Private Capital Group, LLC Puma Biotechnology, Inc. Transaction History

Private Capital Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$8.75 - $12.85 $446 - $655	-51 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$12.3 - $35.76 $627 - $1,823	51 New	51 $3,000
Q3 2018 Oct 31, 2018	SELL	$41.2 - $59.85 $2,101 - $3,052	-51 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$48.3 - $68.25 $289 - $409	-6 Reduced 10.53%	51 $3,000
Q1 2018 May 16, 2018	SELL	$59.7 - $99.25 $131,459 - $218,548	-2,202 Reduced 97.48%	57 $4,000
Q4 2017 May 18, 2018	BUY	$93.85 - $132.45 $157,011 - $221,588	1,673 Added 285.49%	2,259 $12,000
Q4 2017 Mar 07, 2018	BUY	$93.85 - $132.45 $54,996 - $77,615	586	586 $165,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $110M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.